Tivortin®
Active substance formulated into Tivortin® – L-arginine amino acid — is the only substrate for nitric oxide (NO) synthesis in humans.
Tivortin® aspartate is a potent vasodilator, vascular tone regulator.
Tivortin® aspartate is a universal angioprotector:
♦ reduces activation and adhesion of leukocytes to the endothelium;
♦ has antithrombotic properties, reduces platelets adhesion, their activation and aggregation;
♦ prevents pathological vascular remodeling and atherosclerosis progression.
Xylat-Tivortin course Life Extension
40+ is a wonderful age to discover yourself, to accept your body as the greatest value, but this age is special.
During this period of life, a woman needs additional care: energy saturation, acceleration of metabolism, improvement of microcirculation of tissues and organs to normalize their work and prevent the development of cardiovascular diseases.
Xylat-Tivortin course is designed specifically to improve the quality of life of women.
Xylat-Tivortin course Life Extension:
- provides energy and emotional uplift
- raises the standard of living and improves the women status at menopausal age
- reduces the manifestations of menopause
- edema decreases, due to which body weight decreases
The mechanism of influence of the Life Extension course on a woman’s body:
- restoration of energy metabolism in cells
- improving carbohydrate metabolism
- support of vascular endothelial function
- improvement of microcirculation
Watch the video report (in Ukrainian) of Professor Lakhno Igor Viktorovich about Xylato-Tivortin Life Extension course (from 18:35 minute):
See the instructions for medicines included in the Xylat-Tivortin course:
Xylat || Tivortin || Tivortin aspartate
How supplied
Sales markets
Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Ukraine.
Articles
- Cardioprotector effect of nitrogen oxide donor in patients with hypertension
- State of metabolic processes and ways to improve them in premenopausal women due to the Life Extension Strategy
- Pathogenetic pancreoprotection in diabetic ketoacidosis
- Healthy nephrone — a guaranty of stable blood pressure
- Metabolic regulation in mitochondria as a prospective way of body rejuvenation
- What should a practitioner know about endothelial dysfunction?
- Pain syndrome in adenomyosis. finding new pathogenesis links and non-hormonal correction opportunities. Literature review (Ukrainian language).
- " Long-haulers ": patients with post-covid syndrome in routine clinical practice
- School of endocrinologist: some aspects of infusion treatment of diabetes
- L-arginine in norm and pathology
- The role of L-arginine in the treatment of cardiovascular diseases: the focus is on the choice of effective dose
- A safe and effective non-prohibited drug for stimulating the performance of athletes
- The efficacy of Tivortin® in the treatment of patients with stable effort angina
- A novel approach to the therapy of placental dysfunction using L-arginine
- Tivortin® in the therapy of placental dysfunction
- L-Arginine in coronary heart disease: the research continues
- L-arginine from the viewpoint of evidence-based medicine